For example, the topoisomerase II inhibitor teniposide induces STING-dependent type I IFN signaling and NF-κB activation in a mouse tumor model, with the consequent DC and T-cell activation promoting antitumor responses, including increased immune cell infiltration (Wang et al. 2019). Here, STING1 is linked to neoplasm.